Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma: reply from the authors. - Matter-Walstra K; Braun R; Kolb C; Ademi Z; Dummer R; Pestalozzi BC; Schwenkglenks M (The British journal of dermatology, 2016)